IDENTIFICATION OF THE SPECIFIC HEMATOPOIETIC STEM CELL POPULATIONS RESPONSIBLE FOR FAILURE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES

被引：0
|
作者：
Ganan-Gomez, I. [1 ]
Alfonso, A. [1 ]
Ogoti, Y. [1 ]
Yang, H. [1 ]
Montalban-Bravo, G. [1 ]
Yu, A. C. [2 ]
Silver, S. [2 ]
Clise-Dwyer, K. [1 ]
Garcia-Manero, G. [1 ]
Colla, S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA
[2] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Houston, TX 77030 USA
来源：
LEUKEMIA RESEARCH | 2017年 / 55卷
关键词：
D O I：
10.1016/S0145-2126(17)30165-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
52
引用
收藏
页码：S34 / S36
页数：3
相关论文
共 50 条
  • [1] IDENTIFICATION OF THE SPECIFIC HEMATOPOIETIC STEM CELL POPULATIONS RESPONSIBLE FOR FAILURE TO HYPOMETHYLATING AGENTS IN MYELODYSPLASTIC SYNDROMES
    Ganan-Gomez, I.
    Alfonso, A.
    Ogoti, Y.
    Yang, H.
    Montalban-Bravo, G.
    Yu, A. C.
    Silver, S.
    Clise-Dwyer, K.
    Garcia-Manero, G.
    Colla, S.
    HAEMATOLOGICA, 2017, 102 : 258 - 258
  • [2] Hematopoietic Cell Transplantation in Myelodysplastic Syndromes after Treatment with Hypomethylating Agents
    Festuccia, Moreno
    Baker, Kelsey
    Gooley, Theodore A.
    Sandmaier, Brenda M.
    Deeg, H. Joachim
    Scott, Bart L.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (09) : 1509 - 1514
  • [3] The role of hypomethylating agents prior to hematopoietic cell transplantation in myelodysplastic syndromes
    Sekeres, Mikkael A.
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2018, 31 (04) : 346 - 350
  • [4] Hematopoietic cell transplantation in Myelodysplastic Syndrome after Failure of Hypomethylating Agents
    Festuccia, M.
    Deeg, J.
    Scott, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S75 - S75
  • [5] Beyond hypomethylating agents failure in patients with myelodysplastic syndromes
    Zeidan, Amer M.
    Kharfan-Dabaja, Mohamed A.
    Komrokji, Rami S.
    CURRENT OPINION IN HEMATOLOGY, 2014, 21 (02) : 123 - 130
  • [6] Response to pretransplant hypomethylating agents influences the outcome of allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndromes
    Yahng, Seung-Ah
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Lee, Sung-Eun
    Cho, Byung-Sik
    Lee, Dong-Gun
    Eom, Ki-Seong
    Lee, Seok
    Min, Chang-Ki
    Kim, Hee-Je
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    Kim, Tai-Gyu
    Park, Chong-Won
    Kim, Yoo-Jin
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2013, 90 (02) : 111 - 120
  • [7] Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes
    Liu, Liu
    Jia, Menglu
    Sun, Ling
    Tian, Wenliang
    Tang, Ping
    Jiang, Zhongxing
    CLINICAL AND EXPERIMENTAL MEDICINE, 2021, 21 (04) : 537 - 543
  • [8] A meta-analysis of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in patients with myelodysplastic syndromes
    Wang, X.
    Liang, X.
    Zeng, D.
    Zhang, C.
    Zhang, X.
    Liao, J.
    Ma, Y.
    Yi, A.
    Sun, A. -H.
    Kong, P. -Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S509 - S509
  • [9] Meta-analysis of the benefit of hypomethylating agents before allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes
    Liu Liu
    Menglu Jia
    Ling Sun
    Wenliang Tian
    Ping Tang
    Zhongxing Jiang
    Clinical and Experimental Medicine, 2021, 21 : 537 - 543
  • [10] Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromes
    Kim, Yundeok
    Kim, In-Ho
    Kim, Hyeong Joon
    Park, Silvia
    Lee, Kyoo-Hyung
    Kim, Soo Jeong
    Lee, Jung-Hee
    Kim, Dae-Young
    Yoon, Sung-Soo
    Kim, Yeo-Keoung
    Jang, Jun Ho
    Park, Seon Yang
    Ahn, Jae-Sook
    Cheong, Chul Won
    Lee, Je-Hwan
    Cheong, June-Won
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2014, 99 (05) : 635 - 643
12345